(Q44923612)

7 December 2017

title

Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne (English)

1 reference

7 December 2017

main subject

Propionibacterium acnes

object named as

Propionibacterium acnes

1 reference

Fabiola Schafer

1

1 reference

7 December 2017

Felix Fich

2

1 reference

7 December 2017

Marusella Lam

3

1 reference

7 December 2017

Cynthia Gárate

4

1 reference

7 December 2017

Aniela Wozniak

5

1 reference

7 December 2017

Patricia Garcia

6

1 reference

7 December 2017

publication date

22 February 2013

1 reference

International Journal of Dermatology

7 December 2017

published in

1 reference

7 December 2017

volume

52

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

418-425

1 reference

7 December 2017

cites work

Clinical practice. Acne

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Acne and Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Benzoyl peroxide and adapalene fixed combination: a novel agent for acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Antibiotic-resistant acne: lessons from Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Laboratory Induction and Clinical Occurrences of Combined Clindamycin and Erythromycin Resistance in Corynebacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

European surveillance study on the antibiotic susceptibility of Propionibacterium acnes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Trimethoprim and sulfonamide resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Trimethoprim resistance in enterobacteria isolated in Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Bacterial resistance in French acne patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

Treating acne with antibiotic-resistant bacterial colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2011.05371.X

10.1111/J.1365-4632.2011.05371.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference